EIF2AK3 and Parkinson disease: Of these kinases, CDK5 and PERK have been studied in PD brain, with CDK5 localizing to Lewy bodies (Brion and Couck, 1995; Nakamura et al., 1997) and PERK increased in PD substantia nigra neurons (Hoozemans et al., 2007).